Avail a limited period discount of 33% on our uniquely designed Opportunities and Strategies market research reports. Contact us today and make winning strategies!

The cardiovascular drugs market is forecasted to achieve significant growth in the coming few years with a forecast CAGR (compound annual growth rate) of more than 7%, as per The Business Research Company’s market report!

Read More On The Cardiovascular Drugs Market Report 2022 – https://www.thebusinessresearchcompany.com/report/cardiovascular-drugs-global-market-report

The Cardiovascular Drugs Market Size In 2022 And Forecast

The global cardiovascular drugs market is expected to grow from $146.51 billion in 2021 to $153.60 billion in 2022 at a compound annual growth rate (CAGR) of 4.8%. The growth in the market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The cardiovascular drugs market is expected to reach $205.71 billion in 2026 at a CAGR of 7.6%.

The cardiovascular drugs market consists of sales of cardiovascular drugs by entities (organizations, sole traders and partnerships) that produce cardiovascular drugs to treat cardiovascular diseases.

Request for A Sample Of The Global Cardiovascular Drugs Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2134&type=smp

Chronic Disease Prevalence Is Driving The Growth Of The Cardiovascular Drugs Market

According to the World Health Organization, chronic disease prevalence is rose by 57% globally, in the year 2020. These factors are expected to increase the patient pool globally, thereby driving the cardiovascular drugs market during the forecast period.

Competitive Landscape And The Regional Analysis Of The Cardiovascular Drugs Market

Major players in the cardiovascular drugs market are Medtronic Inc., Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences, Cardinal Health, Inc., Johnson & Johnson, Terumo Corporation, Getinge Group, Teleflex Inc. and Becton Dickinson.

Additionally, as per TBRC’s research – North America was the largest region in the cardiovascular drugs market in 2021 holding the largest market share and Middle East is expected to be the fastest-growing region in the forecast period.

The Cardiovascular Drugs Global Market Report 2022  covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the cardiovascular drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the cardiovascular drugs market.

NOACs – A Key Trend In The Cardiovascular Drugs Market

Anti-coagulants have long been used in prevention of thrombus formation in patients suffering with cardiovascular diseases. Use of NOACs makes it easier for patients to continue therapy post discharge as opposed to injections of Heparin and Warfarin which need medical assistance for administration. Some of the NOACs include Pradaxa (dabigatran etexilate) from Boehringer Ingelheim, Xarelto (rivaroxaban) from Janssen, and Eliquis (apixaban) from Bristol-Myers Squibb.

Cardiovascular Drugs Market Segmentation By The Business Research Company

1) By Type: Anti-Hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs for Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic and Anti-Anginal Drugs)

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others

3) By Route of Administration: Oral, Parenteral, Others

4) By Drug Classification: Branded Drugs, Generic Drugs

5) By Mode of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs

Here Are Some Reports Related To The Cardiovascular Drugs Market –

Cardiovascular Devices Global Market Report 2022

Cardiovascular Surgery Devices And Equipment Global Market Report 2022

Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2022

Get In Touch With Us – Call us at:

Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Found This Article Helpful? Share It On: